Disclosure Panels Details Page
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel - Disclosures as of 04/09/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Saundra Buys MD | None | None | None | None | - |
| Mary Daly MD, PhD, FACP | None | None | None | None | ✔ |
| Susan Darlow PhD | None | None | None | None | ✔ |
| Patricia Dickson MD | None | None | None | None | ✔ |
| Susan Domchek MD | None | None | None | None | ✔ |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Ahmed Elkhanany MD | None | Biotheranostics Pfizer Inc. |
None | None | ✔ |
| Susan Friedman DVM | None | None | None | None | ✔ |
| Michael Goggins MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Ashley Hendrix MD, MBA | None | None | None | None | ✔ |
| Mollie Hutton MS, CGC | None | None | None | None | - |
| Beth Karlan MD | None | None | Grail Merck & Co., Inc. MercyBio Roche Laboratories, Inc. |
None | ✔ |
| Seema Khan MD | None | None | None | None | ✔ |
| Catherine Klein MD | None | None | None | None | ✔ |
| Wendy Kohlmann MS, CGC | None | None | None | None | ✔ |
| Allison Kurian MD, MSc | None | None | None | None | - |
| Christine Laronga MD, FACS | None | None | None | None | ✔ |
| Jennifer Litton MD | AstraZeneca Pharmaceuticals LP EMD Serono Genentech, Inc. paxman scalp cooler Pfizer Inc. zenith |
None | clinical care options Medlearning Medscape Physicians Education Resource Prime Oncology uptodate |
Up To Date | ✔ |
| Julie Mak MS, MSc, CGC | None | None | None | None | ✔ |
| John Mansour MD | None | None | None | None | ✔ |
| Carolyn Menendez MD | None | None | None | None | ✔ |
| Sofia Merajver MD, PhD | None | None | None | Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. | ✔ |
| Barbara Norquist MD | None | None | None | None | ✔ |
| Kenneth Offit MD, MPH | None | None | None | None | ✔ |
| Tuya Pal MD | None | None | None | None | ✔ |
| Holly Pederson MD | None | Myriad Genetic Laboratories, Inc. | None | None | ✔ |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | ✔ |
| Gwen Reiser MS, CGC | None | None | None | None | ✔ |
| Leigha Senter-Jamieson MS, CGC | None | None | AstraZeneca Pharmaceuticals LP | None | ✔ |
| Kristen Shannon MS, CGC | None | Expert Witness | None | None | ✔ |
| Rebecca Shatsky MD | Biocept Genentech, Inc. Oncternal Inc. Phoenix Molecular Designs |
None | None | None | ✔ |
| Kala Visvanathan MD, MHS | Cepheid Optra Health |
None | None | None | ✔ |
| Myra Wick MD, PhD | None | None | None | None | ✔ |
| Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | Janssen Pharmaceutica Products, LP UpToDate |
None | None | ✔ |
| Shuang (George) Zhao MD, MS | Unfunded research collaboration with IDT Unfunded research collaboration with Strata Oncology |
None | None | None | ✔ |